CytoDyn Inks Agreement with Amarex Clinical Research to Prepare Two Phase 2b Clinical Trial Protocols to Explore Two Additional Therapeutic... , a bio technology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced that the Company plans to expand its clinical development program for ... (more)
http://ift.tt/1fosCu2
http://ift.tt/1fosCu2
No comments:
Post a Comment